![](/img/cover-not-exists.png)
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants
Forbes, Michael L, Kumar, Veena R, Yogev, Ram, Wu, Xionghua, Robbie, Gabriel J, Ambrose, Christopher SVolume:
10
Language:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.4161/hv.29635
Date:
October, 2014
File:
PDF, 260 KB
english, 2014